Table 2.
Indications for Antibiotic Use Among Patients Attending Madda Walabu University Goba Referral Hospital, Bale-Goba, from September 2018 to April 2019
| Antibiotics | Type of Infection/Prophylaxis | Total | ||||||
|---|---|---|---|---|---|---|---|---|
| Skin and Soft Tissue | Genitourinary | Gastrointestinal | Bloodstream | Preoperative | Respiratory Tract | CNS | ||
| Ceftriaxone | 33 | 63 | 7 | 10 | 46 | 5 | 4 | 168 |
| Metronidazole | 32 | 22 | 10 | 8 | 26 | 7 | 0 | 105 |
| Vancomycin | 0 | 4 | 5 | 4 | 0 | 37 | 0 | 50 |
| Cloxacillin | 1 | 24 | 4 | 1 | 0 | 3 | 2 | 35 |
| Ciprofloxacin | 1 | 1 | 0 | 2 | 1 | 1 | 12 | 18 |
| Augmentin | 6 | 9 | 1 | 1 | 0 | 0 | 0 | 17 |
| Ceftriaxone and metronidazole | 3 | 0 | 2 | 0 | 2 | 9 | 0 | 16 |
| Ceftriaxone and vancomycin | 4 | 9 | 1 | 0 | 0 | 0 | 1 | 15 |
| Ceftriaxone and azithromycin | 1 | 5 | 3 | 3 | 0 | 2 | 0 | 14 |
| Doxycycline | 5 | 1 | 0 | 0 | 6 | 0 | 0 | 12 |
| Ceftriaxone, metronidazole, azithromycin | 0 | 0 | 1 | 4 | 0 | 0 | 6 | 11 |
| Ampicillin and erythromycin | 1 | 0 | 1 | 3 | 0 | 2 | 3 | 10 |
| Total | 87 | 138 | 35 | 36 | 81 | 66 | 28 | 471 |